ENGNW

enGene Therapeutics Inc. Warrants (ENGNW)

Stock · NASDAQ · Health Care

$0.23as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Industry
Biotechnology: Biological Products (No Diagnostic Substances)

enGene Therapeutics Inc. Warrants Competitors

Chosen by industry and closest market cap.

  • ENGNW
    enGene Therapeutics Inc. Warrants
    $0.23
    ▼ 7.67%
    Market cap $33.75MP/E
  • ALGS
    Aligos Therapeutics Inc. Common Stock
    $6.93
    ▼ 1.98%
    Market cap $34.10MP/E
    $3.98$13.69
  • ESLA
    Estrella Immunopharma Inc. Common Stock
    $0.705
    ▼ 2.10%
    Market cap $32.10MP/E
    $0.6781$3.15
  • ELUT
    Elutia Inc. Class A Common Stock
    $0.885
    ▲ 0.57%
    Market cap $38.95MP/E 0.75
    $0.5$2.4
  • TVGN
    Tevogen Inc. Common Stock
    $6.89
    ▲ 2.07%
    Market cap $41.58MP/E
    $3.64$49.5
  • EVAX
    Evaxion A/S American Depositary Share
    $3.03
    ▼ 3.81%
    Market cap $24.98MP/E
    $2.52$12.15
  • MGX
    Metagenomi Therapeutics Inc. Common Stock
    $1.2
    ▼ 0.83%
    Market cap $46.68MP/E

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.